Culver's Root

What is Culver's Root?

The only complete chemical analysis of Culver's Root, published by Power and Rogerson in 1910, worked through 55.56 kg of the dried root and could not find the "leptandrin" the trade had been selling under that name since about 1850. What they found instead was 3,4-dimethoxycinnamic acid, 2.14 percent mannitol, 0.16 percent essential oil, a 6.2 percent resin and a 1.6 percent bitter amorphous fraction, none of which, in anything indexed in PubMed by October 10 2026, has since been shown to purge, to provoke vomiting or to move bile in a controlled experiment. That is the chemistry behind a root sold today in a 1:3 alcohol extract for "cleanse and detoxify" support.

The plant is Veronicastrum virginicum (L.) Farw., synonyms Leptandra virginica (L.) Nutt. and Veronica virginica L., now placed in the Plantaginaceae after more than a century in the Scrophulariaceae. It is a perennial 3 to 7 feet tall with lance-shaped, sharply toothed leaves in whorls of three to nine around an unbranched stem, topped by dense white flower spikes 3 to 8 inches long from June to September. It is the only Veronicastrum in North America; every other species in the genus is East Asian, where V. sibiricum and V. axillare carry most of the genus's modern pharmacology and none of it transfers to the American plant. The range runs across the eastern United States, but the plant is Endangered in Vermont (listed in 1987 and still on the state's February 2022 list), Threatened under the Massachusetts Endangered Species Act with 7 known occurrences, and Threatened in New York with a state rank of S2.

The commercial part is the rhizome with its wiry roots, gathered in the fall of the plant's second year. The name is usually traced to a physician named Culver about whom the sources say nothing more; Lloyd's 1911 history says only that settlers named the plant after the man who used it in his practice. The oldest dated record I found is from 1716: Oliver Wendell Holmes, in his 1869 lecture on the medical profession in Massachusetts, quotes Cotton Mather writing in 1716 to John Winthrop of New London to obtain Culver's root, then "famous for the cure of consumptions," for his eldest daughter Katharine, who died the following month.

Common Names

• Culver's root, Culver's physic, black root, blackroot

• Leptandra (the pharmacopeial name, also the name of a Lloyd Brothers product)

• Bowman root, Brinton root, physic root, tall speedwell, tall veronica, whorlywort

• Hini (Osage and Missouri, per Lloyd 1911), quitel (Delaware)

• Leptandrae rhizoma, Fluidextractum Leptandrae, Extractum Leptandrae

Primary Active Compounds

• 3,4-dimethoxycinnamic acid, 5.0 g crystallized from the water-soluble fraction by Power and Rogerson in 1910, melting point 180 to 181 degrees C, which they described as "the first instance in which 3,4-dimethoxycinnamic acid has been observed to occur in nature"

• A brown, amorphous, "intensely bitter, nauseous" fraction at 1.6 percent of the dried drug, which on hydrolysis gave cinnamic acid and p-methoxycinnamic acid

• A water-insoluble resin at 6.2 percent, containing the phytosterol verosterol, p-methoxycinnamic acid as an ester, and oleic, linoleic, palmitic and stearic acids

• Mannitol at 2.14 percent, first reported by E. S. Wayne in the American Journal of Pharmacy in 1859

• An essential oil at 0.16 percent, dark brown, distilling at 120 to 160 degrees C at 25 mm pressure, never characterized further

• Alkaloids: a 10 g test gave reactions "so slight as to indicate the presence of not more than traces"

Key Note

"Leptandrin" is two different things in the record and neither is a defined molecule. From about 1850 it was William Stanley Merrell's trade name for a black, tasteless resin precipitated by pouring a thick tincture into cold water. Separately, the bitter crystalline substance E. S. Wayne reported in 1856, which F. F. Mayer in 1863 and Lloyd in 1880 took to be a glucoside carrying the activity, was given the same name. Power and Rogerson, with H. H. Dale running the animal tests, could confirm neither: "It has not been possible to confirm the statement recorded in the literature that leptandra contains a crystalline, bitter glucoside, designated as leptandrin." The Dispensatory of the United States in 1918 and the British Pharmaceutical Codex in 1911 both carried that negative. Nothing in the 36 Veronicastrum records PubMed held on October 10 2026 reverses it.

So a buyer holding a bottle of Culver's root holds a plant whose purgative principle was never isolated, whose named active compound was a marketing term, and whose safety depended, according to every compendium that carried it, on a handling step no label now reports.

Primary Functions & Benefits

Culver's root entered the pharmacopeias on three claimed actions: cathartic, emetic and cholagogue. None of the three has been measured in a person in a controlled study, and the one laboratory test of the isolated fractions came back negative.

Cathartic action. The use everyone agreed on. William Cook in 1869 described the dried root as "an almost pure relaxant" whose cathartic result was "rarely being obtained from a common dose in less than ten hours, and sometimes not for eighteen hours," calling it "the slowest of all agents of this class." King's in 1898 said that in ordinary doses "it does not produce copious alvine discharges." The 1918 Dispensatory was blunter: "In the dried state it is much milder, but less certain." So the historical consensus was a slow, mild, unreliable laxative from dried root and a violent one from fresh. Native use in Moerman's database, 39 entries across the Cherokee, Chippewa, Iroquois, Menominee and Meskwaki, is dominated by "physic," "cathartic" and "emetic" from root decoctions, with one Iroquois entry recording the plant as "considered poisonous."

Emetic action. This belongs to the fresh root and to strong decoctions. Densmore's 1932 Menominee record lists a "strong decoction of root taken as powerful emetic," and the Iroquois record lists an infusion taken as an emetic. In the Eclectic texts emesis appears only as an adverse effect of fresh material. In 1910 Dale gave a dog 5 g of the total alcoholic extract and it vomited, which the authors attributed "to its nauseous taste and irritant effect on the stomach rather than to any specific action." That is the entire experimental record on emesis.

Cholagogue action, the claim the modern products rest on. The Eclectic school's central assertion was that the dried root stimulated bile. King's called the extract "a powerful cholagogue" and "the only known medicine that efficiently stimulates and corrects the hepatic secretions." The evidence against that is older than the modern supplement industry. Rutherford and Vignal, in bile-fistula experiments published in the Journal of Anatomy and Physiology in 1876, gave two dogs 6 and 12 grains of the resinoid "leptandria" and found that it "undoubtedly stimulates the liver, but its power is very feeble." The 1918 Dispensatory compressed that to "rather feebly." What was tested was the water-precipitated resin that King, Lloyd and Scudder called nearly inert, not the extract or the root. Dale in 1910 gave dogs 1 g of the crude resin and 1 g of the bitter fraction by mouth "without any visible effect." And John Milton Scudder, the Eclectic behind Specific Medication, wrote in 1870: "it is probable that we will have to give up the idea of cholagogues entirely," while still believing leptandra did something to the liver he could not name. One 1957 paper in Farmakologiia i Toksikologiia (volume 20, pages 75 to 77) by Petrovskii and colleagues reports a cholagogue study of Veronica virginica with three other plants; it is in Russian, PubMed holds no abstract, and I could not read its result.

What has not been shown. No change in stool frequency, transit time, serum bile acids, gallbladder emptying, liver enzymes or any symptom score has been measured in people taking Veronicastrum virginicum in anything PubMed or ClinicalTrials.gov indexed as of October 10 2026. The gastroprotective and anti-inflammatory papers on V. axillare in rats and the immunosuppressive diterpenes from V. sibiricum are different species with different chemistry, not evidence for this one.

Forms & Standardization

This root has never had a marker compound, so "standardization" here means the specifications the compendia once wrote and the ratios the current labels print. They are not the same kind of number.

Dried rhizome and roots, the compendial article. National Formulary IV (1916) defined leptandra as "the dried rhizome and roots of Veronica virginica Linné, without the presence of more than 5 per cent. of stems or other foreign matter," with a limit of "not more than 12 per cent. of ash." The rhizome was described as 4 to 10 cm long and 4 to 13 mm thick, grayish-brown to dark reddish-brown, with starch grains 0.002 to 0.008 mm across in the powder. Those two limits, 5 percent foreign matter and 12 percent ash, are the only quantitative quality specifications Culver's root has ever carried in an American compendium, and both lapsed when the article left the National Formulary. Neither measures potency.

The age requirement, in the sources' own words. King's 1898: the root "should be well dried and at least one year old after collecting." The BPC 1911: "It should be kept for a year before it is used." Cook 1869: the root "possesses its full strength when two years old." Harding's 1936 collector's manual: "it is said that it should be kept at least a year before being used." The sources also disagree with each other. King's states that "age does not impair its virtues," while Cook says the root contains "a volatile principle that is lost by age." Power and Rogerson measured 0.16 percent essential oil in commercial dried drug of unknown age; I found no measurement of what a fresh root carries. Whichever side is right, the period consensus was that the root changes with storage and that fresh root is a different drug.

Fluidextract, USP VIII. Leptandra in No. 60 powder, 100 parts, exhausted with 71 percent alcohol to produce 100 parts: a 1:1 by weight to volume. The BPC 1911 gives the average dose as 1 mL, which it converts as 15 minims. King's gives 10 to 60 minims one to three times a day. This was the preparation the pharmacopeia actually recognized through the eighth revision of 1905, and it was gone from the ninth.

Extract, USP VIII. The fluidextract evaporated to dryness below 70 degrees C and cut with powdered licorice root to 25 parts from 100, average dose 4 grains (about 260 mg). A four-fold concentrate of the fluidextract, by the BPC's description, padded with licorice to make it workable.

Leptandrin, the resinoid. Introduced about 1850 by William Stanley Merrell, the Cincinnati druggist whose firm eventually became Lloyd Brothers. Made by pouring a syrupy evaporated tincture into cold water, collecting the black tarry precipitate and washing it until it was tasteless. Yield about 6 percent of a well-dried root at least a year old, rising with age, so roots of "two or more years" were preferred for making it. Greve and John Uri Lloyd both judged it inferior; Lloyd found that water shaken with the resin gave a colorless, nearly tasteless filtrate while the dried alcoholic extract gave a dark, extremely bitter one, differing "so markedly" as "to forbid their substitution for each other." By 1898 King's recorded that "neither leptandrin nor other resinoids are used to any great extent by Eclectic physicians." BPC 1911 nonetheless noted the resinoid was "a constituent of many American nostrums," dosed at 2 to 5 grains.

Dried alcoholic extract. The form John King actually used, yield about 10 percent of the root, bitter, hygroscopic enough that it was hard to dry "without the addition of magnesia or some other absorbent." Dose 1 to 5 grains in pills, roughly 65 to 325 mg.

Specific Medicine Leptandra. The Lloyd Brothers product, the firm having taken that name in 1886 when Curtis Gates Lloyd joined John Uri and Nelson Ashley Lloyd. King's called it "the most extensively used preparation," dark brown, turning milky in water, dosed at 2 drops to 1 fluid drachm. Felter 1922 gives 1 to 60 drops. Specimen bottles labeled Leptandra survive in the Lloyd Library's collection of the firm's products. This is the "Leptandra" a reader will meet in reprinted Eclectic formulae, and it is a specific branded liquid, not a synonym for the dried root.

Tincture of Black Root. King's Eclectic recipe: 3 ounces of powdered root to 1 pint of diluted alcohol, roughly a 1:5, dosed at half to 2 fluid drachms (about 1.8 to 7.4 mL) two or three times a day.

The period prescribing figures, as history. These are nineteenth and early twentieth century figures for a physician-administered drug, listed so a reader who meets them in a reprint knows what they were; they are not recommendations. King's American Dispensatory (1898): powdered root as a cathartic 20 to 60 grains (1.3 to 3.9 g); dried alcoholic extract 1 to 5 grains in pills; Specific Leptandra 2 drops to 1 fluid drachm. Felter (1922): 10 to 60 grains of the drug, 1 to 60 drops of Specific Medicine Leptandra, resinoid leptandrin 1/4 to 2 grains. BPC (1911): 1 to 4 g of the dried rhizome, fluidextract 1 mL. The 1918 Dispensatory: 15 to 60 grains (1 to 3.9 g); impure resin 2 to 4 grains. A 3.9 g upper figure for a purgative dose and a 1 g lower figure for a "tonic" dose is a four-fold spread that the sources never reconciled.

Current liquid extract. Herb Pharm's Culver's Root is a 1:3 herb-to-menstruum extract of "rhizome with rootlet" in 66 to 76 percent certified organic cane alcohol and distilled water, 233 mg of herb per 0.7 mL serving, about 42 servings in a 1 ounce bottle listed at $18.98, grown on the company's Regenerative Organic Certified farm in southern Oregon, sold under the category "Cleanse and detoxify." It is about 1.7 times stronger per mL than the Eclectic 1:5 tincture and one third the strength of the 1:1 fluidextract. The label does not say fresh or dried, and does not give an age.

Homeopathic preparations, which go the other way. Madaus recorded in 1938 that the German Homeopathic Pharmacopoeia (HAB, section 3) specified fresh, two-year-old roots for Leptandra, and his own "Teep" fresh-plant trituration tablet carried 0.125 g of root. Boiron sells Leptandra virginica 30C pellets in the United States under NDC 0220-3095-41 labeled "Relieves dark colored diarrhea worsened by cold drinks," with the advice to stop after 3 days if symptoms persist. At 30C there is no root left to be fresh or dried; the point is that the homeopathic tradition started from the fresh root the Eclectic one forbade, under the same Latin name.

Bulk cut root. Wholesale listings I checked give no origin country, no harvest year and no statement of drying.

Standardized extract. None exists, because no marker was ever agreed.

Food Sources

Culver's root is not a food and never was one. Scudder wrote in 1870 that the infusion "is so nauseous that most persons object to it," and Power and Rogerson's 1.6 percent bitter fraction and 6.2 percent resin are the reason. The only food-like constituent is mannitol at 2.14 percent of the dried root, a sugar alcohol found in mushrooms and celery, and a 233 mg serving of root carries about 5 mg of it. There is no GRAS listing, no food additive use and no culinary tradition anywhere in the 39 ethnobotanical entries, all of which are drug uses.

The plant itself is widely sold as an ornamental, as nursery cultivars such as 'Fascination' and 'Album' and as straight-species seed and plugs. That matters for two reasons. A gardener who reads that the root is a laxative has fresh root in the ground, which is exactly the form the compendia warned against. And a wild-harvester has a plant that is Endangered in Vermont, Threatened in Massachusetts and Threatened in New York.

Who Should Take Culver's Root

Nobody needs Culver's root. It is not a nutrient, no deficiency state exists, and no trial shows any condition improving on it. The defensible buyer is narrow: an adult who wants a bitter laxative for occasional, uncomplicated constipation, who understands that the evidence is Eclectic clinical opinion from 1852 to 1922 and that a dog study in 1910 found the isolated fractions inactive, and who will stop after a few days whether or not it works.

Plausible candidates. An adult with occasional sluggish bowels and no red-flag symptoms, who has already tried fiber and fluids, taking a dried-root extract from a company that states plant part, country of origin and species.

Who should look elsewhere first. Anyone whose goal is a "liver cleanse," because no measurement of liver function in a person taking this root is indexed in PubMed or ClinicalTrials.gov as of October 10 2026, and the only laboratory tests of the cholagogue claim, on the resinoid in 1876 and the fractions in 1910, came back "very feeble" and negative. Anyone with chronic constipation, where psyllium and polyethylene glycol 3350 have controlled trials and this root has none. Anyone with gallbladder symptoms, where a bile-stimulating herb is a hazard rather than a help if a stone is present.

Who Should AVOID or Use Caution

Contraindications

• Pregnancy. King's 1898 recorded that the fresh root "administered to the pregnant female has produced miscarriage" and Felter 1922 recorded that it "has produced bloody stools and abortion." No source distinguishes a safe dose of dried root in pregnancy, and no product label states that its root was dried. The Meskwaki record in Moerman lists the root as "used by women in labor," which points the same way.

• Breastfeeding. No excretion data, no infant exposure data. A laxative with an uncharacterized active principle has no place here.

• Children. No pediatric data of any kind in the modern record. The Eclectic use in "diarrhoea of dentition" and cholera infantum was nineteenth century physician practice on infants dying of diarrheal disease, and it is not transferable.

• Gallstones or bile duct obstruction. The Drugs.com monograph, which cites Brinker's 1998 Herb Contraindications and Drug Interactions, names "bile duct obstruction, gallstones, internal hemorrhoids, menstruation, and pregnancy." A substance sold as a cholagogue should not be taken where bile cannot drain.

• Inflammatory bowel disease, active ulcer, or any undiagnosed abdominal pain. A purgative on an inflamed gut is a hazard; the Natural Medicines summary says plainly that black root "can irritate the digestive tract, cause vomiting, and act like a laxative."

• Fresh root in any preparation: tea, decoction, fresh tincture, or chewed. This is the one contraindication every compendium agreed on. (Scudder in 1870 did print one correspondent's claim that his family took "a tincture of the recent root" for years without harm; one anecdote does not outweigh four compendia.)

Use Caution

• Anyone taking warfarin, digoxin, furosemide, hydrochlorothiazide or any drug with a narrow therapeutic window, for the reasons in the interactions section.

• Anyone over about 65 or with heart or kidney disease, where a day of purging shifts potassium and fluid in ways a younger person tolerates.

• Anyone with hemorrhoids or rectal bleeding, which the Drugs.com contraindication list names and which a purge aggravates.

• Anyone who cannot establish from the seller whether the root was dried and for how long. That is most buyers.

Critical Safety Point

The fresh root was described in 1898 as capable of "violent emesis and bloody purging, accompanied by vertigo," and the drying step that was supposed to make it safe was never characterized chemically, never tied to a measurable marker, and is not reported on any product label I could find. A reader who grows the plant, buys a "fresh plant tincture," or buys a root of unstated age is not protected by the historical safety claim, because that claim was conditional on a step they cannot verify. Treat any symptom of vomiting, bloody stool or dizziness after this root as a reason to stop and seek care, not a sign that it is "working."

Recommended Dosages

There is no dose established by a trial, because there is no trial. There is no recommended dose here. The nineteenth century prescribing figures were written for a physician-administered drug and sit, as history with their sources, under Forms & Standardization. What follows is the one current label, read as a label.

What the one documented bottle tells you to do. Herb Pharm's 1:3 extract label reads: one full dropper squeeze (0.7 mL, which the ratio makes 233 mg of rhizome), stirred into 2 ounces of water or juice, taken 2 to 4 times daily between meals. Multiply it out and the day's intake is 0.47 to 0.93 g of root equivalent. Set against the Eclectic figures above, that lands at or below the floor of King's tonic range and nowhere near a cathartic dose. A label is not evidence of effect; this one is evidence only of restraint.

Duration

No source gives a safe duration, because the historical use was episodic: a cathartic dose repeated "until it operates," then stopped. The only duration limit on any current product is the homeopathic Boiron label's instruction to stop after 3 days if symptoms persist, which is standard OTC language rather than a finding about this plant. There is no data on daily use beyond a few days, and no reason to take it beyond a few days.

Timing & Administration

The current label says between meals. The historical texts say nothing about meals and everything about waiting: Cook in 1869 put the cathartic result at 10 to 18 hours after a dose of dried root, "the slowest of all agents of this class," and warned that the stomach "feels its impression" as "a slight sense of nausea" that "sometimes is quite unpleasant and continues for several hours." An evening dose, if anyone is going to take one, lands its effect the next day. Taking a second dose because the first has not acted in four hours is the mistake the slowest cathartic in the class invites.

The Eclectic "every hour until it operates" schedules were bedside physician regimens for acutely ill patients and belong in the history, not in a kitchen.

A 0.7 mL serving at 66 to 76 percent alcohol is about 0.5 mL of ethanol, trivial for most adults and not trivial for someone avoiding alcohol entirely.

Timeline of Effects

Onset. Historical observation only: 10 to 18 hours for a cathartic effect from dried root (Cook 1869); nausea within hours. No modern measurement.

Peak. Not measured in any study.

What counts as a fair trial. For a laxative, two days. If nothing has happened 48 hours after a label dose, the preparation is not going to work at that dose, and increasing it moves toward the historical purgative range where vomiting and cramping were the recorded effects.

When to conclude it is not working. For the "liver support" or "detox" purpose, there is no timeline, because there is no measurable endpoint. No study indexed in PubMed or registered on ClinicalTrials.gov as of October 10 2026 has followed liver enzymes, bilirubin, bile acids or gallbladder volume in a person taking this root for any duration, so there is nothing to wait for.

Benefits of Taking Culver's Root

There are no demonstrated benefits in the controlled sense. What exists is a record of use by physicians who believed in it, and that record is worth reading as history.

Lloyd's 1911 history traces the drug from its being "employed in decoction by settlers and savages alike as a violent purgative," through Peter Smith's Indian Doctor's Dispensatory of 1813, to its "general introduction to the profession of medicine" in the American Dispensatory of 1852 on the recommendation of Professor W. Byrd Powell to John King. From there it was an Eclectic staple for "biliousness," constipation with "hepatic torpor," early dysentery, and as a follow-up to quinine in malaria. King's claimed that combined with podophyllum resin it "often" cured epidemic dysentery "in from 12 to 18 hours." Ellingwood in 1919: "it is certainly under-estimated." Felter in 1922 said its "field of usefulness has narrowed down to gastro-hepato-duodenal atony."

Every one of those claims comes from uncontrolled practice in an era without diagnostic categories we would recognize. The one physiological hypothesis they shared, that the root increased bile flow, was tested on the resinoid in two of Rutherford's dogs in 1876 and found "very feeble," and the isolated fractions did nothing in Dale's dogs in 1910. The benefit a modern buyer can honestly expect is the one Cook described: a slow, mild, bitter laxative effect from a dried root, with some nausea.

Potential Negatives & Side Effects

Recorded in the period sources for dried root. Nausea lasting several hours (Cook 1869). Slow, uncertain purgation. Clay-colored or black, tarry stools were treated as signs of action rather than side effects.

Recorded for fresh root. Violent vomiting, bloody purging, vertigo and miscarriage (King's 1898; Felter 1922). The Dispensatory of 1918: "The recent root is said to act violently as a cathartic, and sometimes as an emetic."

Reported in the modern monograph literature. The Natural Medicines summary lists "stomach pain or cramps, changes in stool color or odor, drowsiness," and adds that "large doses have been linked to reports of liver damage." I could not find the case report behind the liver statement, and a PubMed search on October 10 2026 across all 36 Veronicastrum records found no human toxicity report, so treat that line as an unsourced caution rather than a documented event. Drugs.com states "No health hazards have been associated with proper administration," which is a statement about the absence of reports, not the presence of safety data.

Electrolyte and fluid loss. Any purgative dose carries it. There is no measurement for this root specifically.

Deficiency Symptoms

No deficiency state exists. Culver's root supplies nothing the body requires, and no constituent in it is essential.

What Culver's root addresses

Historically, a symptom cluster the Eclectics called "biliousness": constipation, coated tongue, frontal headache, clay-colored stools, "tenderness and heavy pain in the region of the liver, with drowsiness, dizziness, and mental depression" (Felter 1922). None of those is a deficiency of anything, and most of them map today onto conditions with their own diagnoses.

Bottom line

Nobody is short of Culver's root. The contrast with a genuine trace element is total: iron has a recommended intake, a deficiency syndrome and a blood test. This root has a dose range from 1898 and no biomarker.

Toxicity Symptoms

At high intake

The recorded toxic picture is the fresh-root picture: "violent emesis and bloody purging, accompanied by vertigo" (King's 1898), "bloody stools and abortion" (Felter 1922). The only quantified animal observation on the whole extract is Dale's 1910 dog, which vomited after 5 g of the total alcoholic extract of dried root, a dose equivalent to roughly 14 to 19 g of root given at once, 3.5 to 5 times the 3.9 g top of the historical cathartic range. No LD50 has been determined in any species. No human overdose case was indexed in PubMed on October 10 2026.

Signs to reduce or stop

Vomiting, cramping that does not resolve with a bowel movement, any blood in the stool, dizziness on standing, or drowsiness. Vomiting after a laxative dose is not a sign the dose was right.

General note

The historical sources treated the dried root as safe in ordinary doses, and that may well be true, but the margin was never measured. The hazard sits at the fresh end and at purgative doses of either form. The period statement that drying made the root "safe" was an observation that fewer patients vomited blood, not a toxicology finding.

How Culver's Root Works

Nobody knows, and the honest version of this section is a list of what was ruled out.

The purgative principle was never isolated. Wayne in 1856 reported a crystalline bitter substance and took it for the active principle; Mayer in 1863 and Lloyd in 1880 called it a glucoside without isolating one. Steinmann in 1887 crystallized 0.1 percent of a bitter yellow substance that was not a glucoside. Power and Rogerson in 1910 concluded Steinmann's crystals were "highly probable" to be 3,4-dimethoxycinnamic acid contaminated with the bitter amorphous fraction, and that the saponin claim in the literature arose because that fraction "froths strongly on agitation." Dale fed the resin and the bitter fraction to dogs at 1 g each and saw nothing, injected the bitter fraction intravenously and tested it on the isolated mammalian heart, and "no characteristic action could be observed." The conclusion of the only complete analysis was that none of the identified fractions did anything in the animal.

What drying might change, and why nobody can say. The period observation was that fresh root is violent and dried root is mild, and that fresh root has "a faint, almond-like odor" (King's) which "is lost in the drying" (Harding 1936). That pattern, a volatile or labile constituent present in fresh tissue and lost on drying, is consistent with an enzymatically released compound or an unstable glycoside, but I found no published chemical comparison of fresh and dried root. The related Asian species contain 6-O-rhamnopyranosylcatalpol esters, iridoid glucosides reported by Taskova, Gotfredsen and Jensen in Phytochemistry in 2006 for two Veronicastrum species; I could not confirm from the abstract whether V. virginicum was one of them, and no iridoid has been quantified in the American plant or tested for purgation. Neither Power and Rogerson nor any of the 36 Veronicastrum records in PubMed on October 10 2026 reports an anthraquinone from this plant, so the senna and cascara mechanism, which belongs to other issues in this archive, does not apply here.

Bile stimulation, the claim that defined the drug. The Eclectic model was that leptandra acted "upon the gastric, hepatic, and intestinal apparatus" and that its laxative effect was secondary to increased bile reaching the bowel; Cook wrote that "its final cathartic effect is mainly due to the biliary stimulation of the alvine canal." That is a testable claim, and it was tested, on the resin. Rutherford and Vignal's bile-fistula experiments (Journal of Anatomy and Physiology, 1876, Experiments 33 and 34) put 6 and 12 grains of the resinoid, mixed with bile, into the duodenum of two dogs: the secretion rate rose from 1.9 to 2.5 mL per half hour in one, the bile "retained its normal composition," and the verdict was "undoubtedly stimulates the liver, but its power is very feeble," with "scarcely any appreciable effect" unless bile was present to dissolve it. A contemporary digest of Rutherford's nine-part British Medical Journal report on cholagogues (December 14 1878 to February 15 1879) still listed it among the hepatic stimulants, and the 1918 Dispensatory summarized it as "rather feebly." I found no bile-fistula test of the dried extract or the root, and no bile measurement in a human. Dale's 1910 oral doses added nothing. The one plausible, unmeasured route is the ordinary bitter reflex: an intensely bitter liquid in the mouth drives cephalic-phase gastric secretion, the effect any bitter tonic shares, which would make Culver's root an expensive gentian rather than a specific hepatic drug.

What the modern label mechanism is. "Cleanse and detoxify" has no mechanism attached to it on the Herb Pharm page, and no constituent in Power and Rogerson's list has a known detoxifying action.

Synergistic Supplements

There is no tested synergy. The historical combinations are worth listing because readers meet them in reprinted formulae, and one of them is a hazard.

Podophyllum resin. King's Compound Powder of Leptandra: 1 drachm dried alcoholic extract of leptandra, half a drachm podophyllum resin, 5 drachms milk sugar, dosed at 8 grains "repeated every 1 or 2 hours, until it operates freely." Podophyllum resin is a cytotoxic lignan drug with a modern record of fatal poisonings; combining it with anything at home is not a synergy, it is a way to take podophyllin.

Hydrastis, chionanthus, chelidonium, dioscorea. Felter's list of agents that leptandra "acts well with" when "these are also indicated," in his gastro-hepatic atony picture (podophyllum is on the same list). All are nineteenth century "hepatics" and none has a controlled trial for that purpose; goldenseal's berberine story belongs to other issues in this archive.

Quinine. Ellingwood recommended 1/4 to 1 grain of leptandra with each quinine dose in ague. Historical only.

A reader looking for a laxative that stacks sensibly with something has options with actual trials: psyllium with adequate water, or magnesium.

Interactions & What NOT to Take

No documented drug interaction exists for Veronicastrum virginicum; Drugs.com records "None well documented." Everything below is inference from what a purgative does, and the inference is strong enough to act on.

• Warfarin. Diarrhea reduces vitamin K absorption and can raise the INR. Anyone on warfarin should not take a purgative dose of anything, this included.

• Digoxin. Purging lowers potassium, and low potassium increases digoxin toxicity. The Natural Medicines summary flags digoxin too, though on absorption grounds rather than potassium.

• Furosemide, hydrochlorothiazide, chlorthalidone and other potassium-wasting diuretics. Same mechanism, additive potassium loss.

• Any oral medication with a narrow therapeutic index. Faster transit reduces absorption time. The conventional spacing advice carried in the Natural Medicines text is to take other drugs one hour before or four hours after.

• Other stimulant laxatives, including senna, cascara and bisacodyl. Additive purging with no added benefit.

• Ursodiol or any prescribed biliary therapy. A "cholagogue" of unknown activity on top of a gallbladder regimen is an unmeasured variable for a clinician trying to manage a known one.

• Fresh Culver's root in any form alongside dried. The reasons are in the safety sections.

Quality, Testing & Adulteration

This is a root with a documented history of commercial deception, lapsed specifications, and no current third-party program that touches it.

The leptandrin substitutions, 1850 to 1898. King's dispensatory, quoting Dr. T. L. A. Greve, is plain: "under the name of leptandrin various preparations have been sold. Originally, the soft resin was simply dried and powdered but it was found to be nearly inert... Most of the so-called leptandrin made at present for medicinal purposes, is merely a dried aqueous extract, so that our practitioners may observe how much they have been imposed upon heretofore by the representations of some manufacturers." King himself wrote that the powder "being at this day prepared so as to be nearly worthless, I have substituted the extract for it in nearly all the formulae in this work." Scudder in 1870: "The resin is nearly worthless." So the named active product of this plant was, by the admission of the physicians prescribing it, either an inert resin or an aqueous extract passed off as something else.

The name problem. "Bowman root," listed as a synonym for Culver's root by King's, Felter and Harding, is also the standard common name of Gillenia trifoliata (also Porteranthus trifoliatus), a Rosaceae plant called Indian physic that was itself used as an emetic. "Blackroot" is also the common name of Pterocaulon pycnostachyum, an unrelated Asteraceae of the Southeast. "Leptandra" names both the plant and a specific Lloyd Brothers liquid. A buyer searching any of these names can land on three different things, two of which are purgatives.

What the compendia once required and no longer do. National Formulary IV: not more than 5 percent stems or foreign matter; not more than 12 percent total ash; a macroscopic description (rhizome 4 to 10 cm by 4 to 13 mm, annulate, with "numerous coarse roots" below) and a microscopic one (starch grains 0.002 to 0.008 mm, lignified wood fibers, resin fragments that turn pink or violet in chloral hydrate). Those were identity and purity tests. There is no monograph for this root in the current USP, NF or European Pharmacopoeia, no USP Verified product, no NSF certified product and no ConsumerLab test that I could locate.

What a third-party seal would and would not cover. A USP or NSF mark, if one existed, would verify identity against a reference, contaminants and label claim. It would not establish whether the root was dried, how long it was stored, or how old the plant was at harvest, because no specification was ever written for those and no marker exists. The one period assay that tracked age, Lloyd's resin yield rising with storage, measured the inert fraction.

Conservation and sourcing. The plant is state-listed in at least three states and the commercial supply is split between cultivation (Herb Pharm states its own Oregon farm) and wholesale lots of unstated origin. Any product that cannot name a country of origin is, for a plant Threatened in Massachusetts and New York and Endangered in Vermont, a product whose harvest the buyer cannot defend.

What a certificate of analysis for this root ought to carry, and what the buyer can still settle alone. A certificate worth having would state the species as Veronicastrum virginicum with the method used to confirm it (microscopy against the NF description is sufficient and cheap, given the distinctive six-rayed pith and chloral-hydrate-reactive resin cells); the plant part as rhizome and root with a stem fraction; a harvest year; a drying method and a storage interval before extraction; total ash against the old 12 percent limit; moisture; and the usual heavy metal, pesticide and microbial panels. Without a certificate, a buyer can still do three things. Ask the seller in writing whether the root was dried and for how long, and treat silence as the answer. Reject any product described as a fresh-plant extract. And for a liquid extract, check that the ratio, alcohol percentage and mg per serving are all printed and agree, since a 1:3 at 0.7 mL cannot carry more than about 233 mg of herb; one retailer listing I saw printed 629 mg for this same product, which the ratio cannot support.

Special Considerations

The homeopathic line is not the herbal line. Leptandra virginica in homeopathic pharmacopeias has been prepared from fresh root (HAB per Madaus 1938), the exact material the Eclectic texts barred. At 30C that is immaterial; at a mother tincture (1X or "Q" strength, sold by some overseas homeopathic houses) it is a fresh-root preparation, and a reader who buys one on the strength of the Eclectic safety record is applying that record to the wrong form.

Pregnancy, once more. Two independent period sources attributed miscarriage to this root. No modern data overturns that. This is an absolute avoidance, not a caution.

Wild harvesting. Taking rhizome kills the plant. With state listings in Vermont, Massachusetts and New York, a wild-dug root of unstated origin is a conservation problem before it is a quality problem.

Reprinted Eclectic formulae. Specific Medicine Leptandra, dosed in drops, was a manufactured liquid from one Cincinnati firm. Substituting a modern 1:3 or 1:5 tincture drop for drop into a Felter or Ellingwood formula is a guess, because the Lloyd product's strength was never expressed as a ratio a modern label uses.

Research Status & Evidence Quality

Tier 1, controlled human trials of Veronicastrum virginicum: none. I searched PubMed on October 10 2026. "Veronicastrum virginicum" returned 2 records, a 2023 description of a new Chinese species and a 2023 bumble bee survey in which the plant was a forage species. "Leptandra" returned 0. "Veronica virginica" returned 1, the 1957 Russian cholagogue paper with no abstract. The genus name returned 36 records, none a human study of the American species. ClinicalTrials.gov on the same date returned 0 studies for "Veronicastrum" and 0 for "Culver's root." The one registered trial matching "Leptandra" is NCT01049373, a Pascoe-sponsored, placebo-controlled study of 221 chronic low back pain patients given 10 drops three times daily of Lymphdiaral Basistropfen, a 12-ingredient homeopathic combination that includes Leptandra mother tincture, completed May 2007. It is not a study of this root.

Tier 2, animal and laboratory work on this species: Dale's 1910 tests for Power and Rogerson (negative at 1 g of each isolated fraction; vomiting at 5 g of total extract attributed to irritation), and Rutherford and Vignal's 1876 bile-fistula work on the resinoid in two dogs ("undoubtedly stimulates the liver, but its power is very feeble"), read in the authors' reprint from the Journal of Anatomy and Physiology. Neither measured bile from the root or the dried extract.

Tier 3, uncontrolled clinical opinion: the Eclectic literature from the American Dispensatory of 1852 through King's 1898, Ellingwood 1919 and Felter 1922, plus Cook 1869 and Scudder 1870. Internally consistent, never controlled, and candid about its own doubts (Scudder on cholagogues, King on leptandrin).

Tier 4, ethnobotany: 39 entries in Moerman's database across five nations, dominated by cathartic, emetic, febrifuge and "blood cleansing" uses of root decoctions and infusions, with one record of the plant considered poisonous.

Research Limitations

The chemistry stops in 1910. Nothing in PubMed's 36 Veronicastrum records as of October 10 2026 applies a modern separation to this species, compares fresh with dried root, quantifies an iridoid, or runs a pharmacological assay on the American plant. The genus pharmacology that exists (gastric protection and anti-inflammatory activity for V. axillare in rats, immunosuppressive diterpenes from V. sibiricum, four acylated iridoids from V. sibiricum in 2018) is on Asian species with different constituent profiles and cannot be borrowed. The 1957 Russian paper is unreadable to me and may be the only direct bile measurement made since Rutherford. Every safety statement in this issue rests on physicians' observations between 1852 and 1922, which is a thin base for a hazard and a thinner one for reassurance.

Summary & Key Takeaways

Bottom Line

Culver's root is a nineteenth century American purgative whose active principle was never found, whose named active product was admitted by its own prescribers to be "nearly worthless," and whose only safety rule, use dried root at least a year old, is not reported on any current label. The one complete analysis, in 1910, found the isolated fractions inactive in dogs. The one bile measurement I found, on the resinoid in two dogs in 1876, called the effect "very feeble," and the root itself was never measured that way. What is left is a slow, bitter, mild laxative from dried root, sold at 233 mg per serving under a "cleanse and detoxify" banner, with no trial behind it.

Key Safety Points

• Never use fresh root in any form; the recorded effects are violent vomiting, bloody purging, vertigo and miscarriage.

• Do not use in pregnancy, breastfeeding, or children.

• Do not use with gallstones, bile duct obstruction, inflammatory bowel disease, or undiagnosed abdominal pain.

• Do not combine with warfarin, digoxin, potassium-wasting diuretics or other stimulant laxatives.

• Stop at the first sign of vomiting, blood in the stool or dizziness. Those are the fresh-root signs, and a dried root of unknown age can produce them.

Special Note

The reason the Eclectics could prescribe this root was a handling step: harvest in the fall of the second year, dry it, keep it a year. That step was the whole safety margin, it was never characterized, and no company selling the root today says whether it was followed. Until one does, the buyer is trusting a 1911 instruction to a supplier who has not mentioned it.

Researched and drafted with AI assistance. Every claim verified against primary sources and human-reviewed before publication. Last reviewed: October 15, 2026. Corrections: reply to any issue.

This issue is educational and is not medical advice. If you take any medication or have a diagnosed condition, talk to a clinician before adding, stopping or changing anything on the basis of what you read here.